The latest financial statement is for the quarter ending 2026-03-31.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net revenue | - | 15,132 | 19,021 | - |
| Cost of goods sold | - | 6,643 | 8,350 | - |
| Variable sales costs | - | 7,831 | 8,140 | - |
| Other vendor and payroll expenses | - | 3,620 | 3,437 | - |
| Depreciation and amortization | - | 401 | 406 | - |
| Impairment loss on intangibles | - | 3,822 | - | - |
| Stock-based compensation expense | - | 544 | 731 | - |
| Other segment items | - | -218 | -238 | - |
| Net loss | - | -7,947 | -2,281 | -8,756 |
| Loss from continuing operations | -3,435 | - | - | - |
| Depreciation and amortization | 10 | 401 | 406 | 812 |
| Deferred tax expense | - | 0 | 0 | 0 |
| Provision for sales returns | - | -13 | -40 | -49 |
| Amortization of deferred financing cost and debt discounts | 47 | 49 | 41 | 75 |
| Stock-based compensation | 442 | 544 | 731 | 905 |
| Impairment loss on intangibles | - | 3,822 | - | - |
| Allowance for credit losses | - | 0 | 0 | -147 |
| Change in inventory provisions | - | 224 | -31 | 574 |
| Change in fair value of warrant liabilities | 0 | -1 | -18 | -90 |
| Accounts receivable | -5 | -4 | -568 | -897 |
| Inventory | 0 | -3,157 | -1,371 | 5,322 |
| Prepaid and other current assets | -226 | -250 | -24 | 91 |
| Accounts payable, accrued and other liabilities | 508 | -1,532 | -2,337 | 2,905 |
| Cash used in operating activities in continuing operations | -2,197 | - | - | - |
| Cash provided by (used in) operating activities in discontinued operations | 1,834 | - | - | - |
| Cash used in operating activities | -363 | -1,042 | -1,566 | -8,287 |
| Purchase of fixed assets | 4 | 5 | 40 | 6 |
| Cash used in investing activities in continuing operations | -4 | - | - | - |
| Purchase of minority equity investment | - | 0 | 0 | 0 |
| Cash used in investing activities in discontinued operations | 0 | - | - | - |
| Cash used in investing activities | -4 | -5 | -40 | -6 |
| Repayments on seller notes | - | 0 | 0 | 113 |
| Borrowings from midcap credit facilities | 5,870 | 7,137 | 12,752 | 23,424 |
| Repayments for midcap credit facilities | 7,651 | 9,178 | 13,805 | 23,220 |
| Insurance obligation payments | 328 | 100 | 202 | 409 |
| Insurance financing proceeds | 0 | 490 | 0 | 706 |
| Cash (used in) provided by financing activities in continuing operations | -2,109 | - | - | - |
| Cash used in financing activities in discontinued operations | 0 | - | - | - |
| Cash (used in) provided by financing activities | -2,109 | -1,651 | -1,255 | 388 |
| Foreign currency effect on cash and restricted cash | -63 | -27 | -98 | 448 |
| Net change in cash and restricted cash for the period | -2,539 | -2,725 | -2,959 | -7,457 |
| Cash and restricted cash at beginning of year | 6,002 | 8,727 | 19,143 | - |
| Cash and restricted cash at end of period | 3,463 | 6,002 | 8,727 | - |
Aterian, Inc. (ATER)
Aterian, Inc. (ATER)